HEADER CELL ADHESION 12-OCT-11 2LKJ TITLE STRUCTURES AND INTERACTION ANALYSES OF THE INTEGRIN ALPHA-M BETA-2 TITLE 2 CYTOPLASMIC TAILS COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTEGRIN ALPHA-M; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: C-TERMINAL DOMAIN, UNP RESIDUES 1129-1152; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 4 ORGANISM_COMMON: HUMAN; SOURCE 5 ORGANISM_TAXID: 9606; SOURCE 6 OTHER_DETAILS: PEPTIDE PURCHASED FROM GL BIOCHEM KEYWDS MYRISTOYLATED, MAC-1 ALPHA, CYTOPLASMIC, SERINE PHOSPHORYLATED, DPC KEYWDS 2 MICELLES, CELL ADHESION EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR G.L.CHUA,X.Y.TANG,M.AMALRAJ,S.M.TAN,S.BHATTACHARJYA REVDAT 3 20-NOV-24 2LKJ 1 REMARK LINK REVDAT 2 16-NOV-11 2LKJ 1 JRNL REVDAT 1 02-NOV-11 2LKJ 0 JRNL AUTH G.L.CHUA,X.Y.TANG,M.AMALRAJ,S.M.TAN,S.BHATTACHARJYA JRNL TITL STRUCTURES AND INTERACTION ANALYSES OF THE INTEGRIN JRNL TITL 2 ALPHAMBETA2 CYTOPLASMIC TAILS JRNL REF J.BIOL.CHEM. 2011 JRNL REFN ESSN 1083-351X JRNL PMID 22052909 JRNL DOI 10.1074/JBC.M111.280164 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CYANA REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2LKJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 21-OCT-11. REMARK 100 THE DEPOSITION ID IS D_1000102493. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 308 REMARK 210 PH : 5.6 REMARK 210 IONIC STRENGTH : 0 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.7 MM [1H] MYR-P-ALPHA-M-1, 200 REMARK 210 MM [U-99% 2H] REMARK 210 DODECYLPHOSPHOCHOLINE-2, 10 MM REMARK 210 SODIUM PHOSPHATE-3, 10 % [U-99% REMARK 210 2H] D2O-4, 90% H2O/10% D2O; 0.7 REMARK 210 MM [1H] MYR-P-ALPHA-M-5, 200 MM REMARK 210 [U-99% 2H] DODECYLPHOSPHOCHOLINE- REMARK 210 6, 10 MM SODIUM PHOSPHATE-7, 100 REMARK 210 % [U-99% 2H] D2O-8, 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H TOCSY; 2D 1H-1H NOESY; REMARK 210 2D 1H-13C HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : DRX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CYANA 2.1, TOPSPIN 1.3, SPARKY REMARK 210 3.11 REMARK 210 METHOD USED : NULL REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (RES=RESIDUE NAME; REMARK 470 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 470 MODELS 1-20 REMARK 470 RES CSSEQI ATOMS REMARK 470 SEP A 14 P O1P O2P O3P REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 LEU A 2 107.85 -50.87 REMARK 500 1 PRO A 19 66.35 -69.74 REMARK 500 1 ALA A 21 -64.07 -97.03 REMARK 500 1 PRO A 23 82.42 -69.76 REMARK 500 2 LEU A 2 108.14 -50.50 REMARK 500 2 PRO A 19 63.57 -69.76 REMARK 500 2 ALA A 21 -64.46 -96.54 REMARK 500 3 LEU A 2 107.91 -51.09 REMARK 500 3 PRO A 19 63.52 -69.68 REMARK 500 3 ALA A 21 -64.55 -96.51 REMARK 500 4 LEU A 2 107.88 -50.55 REMARK 500 4 PRO A 19 63.47 -69.77 REMARK 500 4 ALA A 21 -64.39 -96.33 REMARK 500 5 LEU A 2 108.12 -50.42 REMARK 500 5 PRO A 19 66.39 -69.70 REMARK 500 5 ALA A 21 -64.13 -96.95 REMARK 500 5 PRO A 23 82.58 -69.70 REMARK 500 6 LEU A 2 108.19 -50.59 REMARK 500 6 PRO A 19 66.51 -69.75 REMARK 500 6 ALA A 21 -63.95 -97.02 REMARK 500 6 PRO A 23 82.07 -69.76 REMARK 500 7 LEU A 2 108.20 -50.01 REMARK 500 7 PRO A 19 63.97 -69.75 REMARK 500 7 ALA A 21 -68.71 -96.98 REMARK 500 8 LEU A 2 108.23 -50.16 REMARK 500 8 PRO A 19 66.09 -69.73 REMARK 500 8 ALA A 21 -64.71 -96.80 REMARK 500 8 PRO A 23 83.72 -69.78 REMARK 500 9 LEU A 2 107.87 -50.74 REMARK 500 9 PRO A 19 63.70 -69.80 REMARK 500 9 ALA A 21 -64.38 -96.33 REMARK 500 10 LEU A 2 107.90 -50.91 REMARK 500 10 PRO A 19 63.82 -69.76 REMARK 500 10 ALA A 21 -64.67 -96.16 REMARK 500 11 LEU A 2 107.88 -50.83 REMARK 500 11 PRO A 19 64.35 -69.81 REMARK 500 11 ALA A 21 -68.54 -97.12 REMARK 500 12 LEU A 2 108.15 -50.50 REMARK 500 12 PRO A 19 63.69 -69.76 REMARK 500 12 ALA A 21 -64.22 -96.05 REMARK 500 13 LEU A 2 107.89 -50.87 REMARK 500 13 PRO A 19 63.87 -69.74 REMARK 500 13 ALA A 21 -69.06 -99.90 REMARK 500 14 LEU A 2 107.87 -50.80 REMARK 500 14 PRO A 19 63.99 -69.75 REMARK 500 14 ALA A 21 -68.74 -96.96 REMARK 500 15 LEU A 2 107.84 -50.79 REMARK 500 15 PRO A 19 66.29 -69.76 REMARK 500 15 ALA A 21 -64.55 -96.76 REMARK 500 15 PRO A 23 81.79 -69.70 REMARK 500 REMARK 500 THIS ENTRY HAS 65 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2LKE RELATED DB: PDB REMARK 900 UNPHOSPHORYLATED VERSION REMARK 900 RELATED ID: 17990 RELATED DB: BMRB REMARK 900 UNPHOSPHORYLATED VERSION REMARK 999 REMARK 999 SEQUENCE REMARK 999 THIS PEPTIDE IS CHEMICALLY SYNTHESIZED WITH REMARK 999 A N-TERMINAL MYRISTATE GROUP AND SERINE 14 PHOSPHORYLATED. REMARK 999 THE CORRECT SEQUENCE IS (MYR)KLGFFKRQYKDMM(SEP)EGGPPGAEPQ, REMARK 999 BUT N-TERMINAL MYR AND A PART OF PHOSPHATE GROUP IN SEP ARE MISSING. DBREF 2LKJ A 1 24 UNP P11215 ITAM_HUMAN 1129 1152 SEQRES 1 A 24 LYS LEU GLY PHE PHE LYS ARG GLN TYR LYS ASP MET MET SEQRES 2 A 24 SEP GLU GLY GLY PRO PRO GLY ALA GLU PRO GLN MODRES 2LKJ SEP A 14 SER PHOSPHOSERINE HET SEP A 14 10 HETNAM SEP PHOSPHOSERINE HETSYN SEP PHOSPHONOSERINE FORMUL 1 SEP C3 H8 N O6 P HELIX 1 1 GLY A 3 GLY A 16 1 14 LINK C MET A 13 N SEP A 14 1555 1555 1.33 LINK C SEP A 14 N GLU A 15 1555 1555 1.33 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1